Small RNA and Oligonucleotides (miRNA & siRNA) |
Electroporation |
Bovine, Murine, E. coli, Human |
<0.5–62% |
[3], [4], [5], [6], [16], [68], [75], [76], [78], [79], [84], [85], [90], [91], [92], [96], [99], [114], [115], [116], [117], [118], [119], [120], [121], [122], [123], [124], [125], [126], [127]
|
|
Chemical Transfection |
Bovine, Human, Murine |
NR-30% |
[6], [76], [127]
|
|
Sonication |
Human |
NR |
[68] |
|
Incubation |
Human, Murine |
70–80% |
[58], [59], [60], [128]
|
Small Molecule Drugs |
Electroporation |
Human, Murine |
0.5–50% |
[7], [8], [9], [64], [67], [80], [116], [129]
|
|
Sonication |
Human, Murine |
8–30% |
[67], [93], [130], [131], [132]
|
|
Incubation |
Bovine, Human, Murine |
1–67% |
[28], [50], [51], [61], [64], [67], [129], [131], [132], [133]
|
|
Thermal Shock |
Human |
10–13% |
[61], [132]
|
DNA and Plasmids |
Electroporation |
Human, Murine |
1.75–20% |
[83], [134], [135]
|
Proteins (e.g. Enzymes and Inhibitors) |
Electroporation |
Bovine, Human |
0.4–0.5% |
[81], [82], [136], [137], [138]
|
|
Incubation |
Murine |
5–19% |
[54], [139]
|
|
Sonication |
Murine |
26% |
[54], [139]
|
|
Thermal Shock |
Murine |
15% |
[54] |
|
Extrusion |
Murine |
22% |
[54] |
Nanoparticles |
Electroporation |
Murine |
7% |
[63] |
|
Sonication |
Murine |
19% |
[63] |
|
Incubation |
Murine |
14–16% |
[63] |
|
Thermal Shock |
Murine |
9–18% |
[63] |
|
Chemical Transfection |
Human |
NR |
[140] |
Gene-Editing Complexes |
Electroporation |
Human |
NR |
[141] |